// App-Quantinova.ai

4837 : Design, synthesis, and biological evaluation of thieno[2,3-d] and thieno[3,2-d]pyrimidines as dual acting RTK inhibitors and microtubule targeting antitumor agents

Researchers

Presenter

  • Aleem Gangjee

Principal Investigators

  • Farhana Islam

  • Tasdique Mohammad Quadery

  • Susan L. Mooberry

  • Anja Bastian

  • Michael A. Ihnat

Medical Centers

  • Duquesne University, Pittsburgh, PA

  • University of Texas Health Science Center, Cancer Center & Research Center, San Antonio, TX

  • The University of Oklahoma College of Pharmacy, Oklahoma, OK.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Solid malignancies

  • PDGFRA rearrangement

Biomarkers

  • Epidermal growth factor receptor

  • Kinase Insert Domain Receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved